Taken together, these observations suggest that the intracellular arginine concentration and its regulation by Arg2 dictate Treg expansion and survival in different microenvironments, and unveil Arg2 as a putative therapeutic target in both autoimmune and neoplastic diseases. Here, ARG2 is linked to neoplasm.